|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash Flows from operating activities: | |||
| Income loss, book value | |||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||
| Depreciation expense | |||
| Amortization expense | |||
| Common stock issued for services | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable | |||
| Other current assets | |||
| Deferred revenue | |||
| Accounts payable and payroll liabilities | |||
| Accrued expenses – related party | |||
| Accounts payable – related party | |||
| Accrued interest | |||
| Accounts payable settled with common stock | |||
| Original issuance discount, net | |||
| Deferred financial costs, net | |||
| Net Cash used in operating activities | |||
| Cash flow from investing activities: | |||
| Fixed asset, net | |||
| Net Cash Provided by Investing Activities | |||
| Net Cash provided by financing activities: | |||
| Common stock issued for cash | |||
| Notes payable | |||
| Note settlement | |||
| Net Cash Provided by financing activities | |||
| Net change in Cash and cash equivalents for the year | |||
| Cash and cash equivalents at the beginning of the year | |||
| Cash and cash equivalents at the end of the year | |||
| Non-cash investing and financing activities: | |||
| PPP loan forgiveness | |||
| Common stock issued for note settlement | |||
| Common stock issued for payable |
Loading...